Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Medicine shortages

Medicine shortage problem is far from solved, warns APPG

Shortages of branded medicines are now less visible than they were two years ago but the problem is still ongoing, according to the All-Party Pharmacy Group (APPG).

The APPG, who held an inquiry into drug shortages two years ago, believes the improvement can be explained by exchange rate fluctuations, with a strong pound leading to a decline in the parallel export of medicines intended for British patients, and that the underlying issues are still a concern.

“The problem is far from solved,” said Kevin Barron, Labour MP and the group’s chairman. “[Medicine] quotas imposed by manufacturers and some wholesalers remain in force. These are often opaque and inflexible, meaning that community pharmacists are still having to spend a large amount of their time negotiating to obtain the medicines their patients need.”

The group, who raise awareness of the pharmacy profession, claimed that pharmacists are having to ration medicines in order to manage drug shortages. It believes the government should be doing more to address the problem, suggesting the Department of Health (DoH) publish updated supply chain guidance addressing best practice in quota setting and management.

The APPG also noted the growing problem in the supply of generic medicines, which was not a concern when the inquiry was held. Some of the causes of generic shortages reflect the globalisation of the generics market, but that cannot be an excuse for “no action here in the UK”, says the APPG.

The statement follows an APPG meeting on drug shortages on 16 July 2014 with representatives from the pharmaceutical industry, wholesalers, the DoH and pharmacy bodies.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20065979

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.